Department of Orthopedic Surgery, The Second Affiliated Hospital, Guangzhou Medical University, Guangzhou, Guangdong, China.
The First School of Clinical Medicine, Southern Medical University, Guangzhou, Guangdong, China.
J Nanobiotechnology. 2023 Aug 8;21(1):258. doi: 10.1186/s12951-023-02036-5.
The development of osteoarthritis (OA) correlates with the expansion of senescent cells in cartilage, which contributes to an inflammatory microenvironment that accelerates matrix degradation and hampers cartilage generation. To address OA, we synthesized small copper sulfide nanoparticles functionalized with anti-beta-2-microglobulin antibodies (B2M-CuS NPs) that catalyze the formation of toxic •OH from HO via peroxidase-like activity. These B2M-CuS NPs are specifically targeted to induce apoptosis in senescent chondrocytes while showing no toxicity toward normal chondrocytes. Furthermore, B2M-CuS NPs enhance the chondrogenesis of normal chondrocytes. Thus, B2M-CuS NPs can effectively treat OA by clearing senescent chondrocytes and promoting cartilage regeneration after intra-articular injection into the knee joints of surgery-induced OA mice. This study uses smart nanomaterials to treat OA with a synergistic strategy that both remodels senescent cartilage and creates a pro-chondrogenic microenvironment.
骨关节炎 (OA) 的发展与软骨中衰老细胞的扩张相关,这导致了炎症微环境,加速了基质降解并阻碍了软骨生成。为了解决 OA 问题,我们合成了一种经过抗β-2-微球蛋白抗体(B2M-CuS NPs)功能化的小硫化铜纳米颗粒,该纳米颗粒通过过氧化物酶样活性将 HO 催化形成有毒的•OH。这些 B2M-CuS NPs 被特异性靶向以诱导衰老软骨细胞凋亡,同时对正常软骨细胞没有毒性。此外,B2M-CuS NPs 还能增强正常软骨细胞的软骨生成。因此,B2M-CuS NPs 通过清除衰老的软骨细胞并在手术诱导的 OA 小鼠膝关节内关节注射后促进软骨再生,可有效治疗 OA。本研究使用智能纳米材料通过协同策略治疗 OA,既能重塑衰老的软骨又能创造有利于软骨生成的微环境。
J Bone Miner Metab. 2019-11-23
Medicine (Baltimore). 2025-8-15
Drug Des Devel Ther. 2025-5-13
Regen Biomater. 2025-3-18
Front Mol Biosci. 2024-9-11
Biomolecules. 2022-7-8
J Nanobiotechnology. 2022-2-19
ACS Appl Mater Interfaces. 2021-12-1